Cary Claiborne
Member Board Of Directors; Audit Committee Chair at NeuroSense Therapeutics - Herzliya, Tel Aviv District, Israel
Cary Claiborne's Colleagues at NeuroSense Therapeutics
Cary Claiborne's Contact Details
HQ
+972 9-953-1142
+972 9-953-1142
Location
Richmond Street,South Wentworthville,New South Wales,2145,Australia
Richmond Street,South Wentworthville,New South Wales,2145,Australia
Company
NeuroSense Therapeutics
NeuroSense Therapeutics
Cary Claiborne's Company Details
Advancing research, development and therapy for ALS and additional CNS indications.NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.Currently in preparations towards a Phase IIb in ALS patients in USA and Israel.
Frequently Asked Questions about Cary Claiborne
Cary Claiborne currently works for NeuroSense Therapeutics.
Cary Claiborne's role at NeuroSense Therapeutics is Member Board Of Directors; Audit Committee Chair.
Cary Claiborne's email address is ***@adialpharma.com. To view Cary Claiborne's full email address, please signup to ConnectPlex.
Cary Claiborne works in the Biotechnology industry.
Cary Claiborne's colleagues at NeuroSense Therapeutics are Niva Blum, Yael Barak, Ron Meitar, Sharon Cohen-Vered, Alon Ben-Noon, Shiran Salomon-Zimri, Nedira Salzman-Frenkel and others.
Cary Claiborne's phone number is +972 9-953-1142